Pila Pharma advances higher doses in PP-CT04 study
Pila Pharma says it has taken the next step toward higher doses in its PP-CT04 study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.